Dangan, Rowena .
HRN: 11-21-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
AMPICILLIN 1GM (VIAL)
08/31/2023
08/31/2023
IVT
2 Gms
Q 6h
PROM X 2 Hours
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes